AUPR814401A0 - Human 3 relaxin - Google Patents

Human 3 relaxin

Info

Publication number
AUPR814401A0
AUPR814401A0 AUPR8144A AUPR814401A AUPR814401A0 AU PR814401 A0 AUPR814401 A0 AU PR814401A0 AU PR8144 A AUPR8144 A AU PR8144A AU PR814401 A AUPR814401 A AU PR814401A AU PR814401 A0 AUPR814401 A0 AU PR814401A0
Authority
AU
Australia
Prior art keywords
relaxin
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR8144A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florey Institute of Neuroscience and Mental Health
Original Assignee
Howard Florey Institute of Experimental Physiology and Medicine
Florey Institute of Neuroscience and Mental Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howard Florey Institute of Experimental Physiology and Medicine, Florey Institute of Neuroscience and Mental Health filed Critical Howard Florey Institute of Experimental Physiology and Medicine
Priority to AUPR8144A priority Critical patent/AUPR814401A0/en
Publication of AUPR814401A0 publication Critical patent/AUPR814401A0/en
Priority to KR10-2004-7005136A priority patent/KR20040063906A/ko
Priority to EP02766975A priority patent/EP1434599A4/en
Priority to CA002462892A priority patent/CA2462892A1/en
Priority to US10/491,919 priority patent/US20050026822A1/en
Priority to IL16129102A priority patent/IL161291A0/xx
Priority to JP2003533961A priority patent/JP2005508944A/ja
Priority to NZ532216A priority patent/NZ532216A/en
Priority to AU2002331460A priority patent/AU2002331460B2/en
Priority to PCT/AU2002/001338 priority patent/WO2003030930A1/en
Priority to IL161291A priority patent/IL161291A/en
Priority to US11/892,215 priority patent/US8841254B2/en
Priority to AU2008201803A priority patent/AU2008201803B2/en
Priority to US12/412,519 priority patent/US20090239805A1/en
Priority to AU2009208063A priority patent/AU2009208063A1/en
Priority to US12/538,128 priority patent/US20110003750A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Addiction (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
AUPR8144A 2001-10-08 2001-10-08 Human 3 relaxin Abandoned AUPR814401A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
AUPR8144A AUPR814401A0 (en) 2001-10-08 2001-10-08 Human 3 relaxin
PCT/AU2002/001338 WO2003030930A1 (en) 2001-10-08 2002-10-02 Human 3 relaxin
JP2003533961A JP2005508944A (ja) 2001-10-08 2002-10-02 ヒト３レラキシン
AU2002331460A AU2002331460B2 (en) 2001-10-08 2002-10-02 Human 3 relaxin
CA002462892A CA2462892A1 (en) 2001-10-08 2002-10-02 Human 3 relaxin
US10/491,919 US20050026822A1 (en) 2001-10-08 2002-10-02 Human 3 relaxin
IL16129102A IL161291A0 (en) 2001-10-08 2002-10-02 Human 3 relaxin
KR10-2004-7005136A KR20040063906A (ko) 2001-10-08 2002-10-02 인간 3 릴랙신
NZ532216A NZ532216A (en) 2001-10-08 2002-10-02 Use of Human 3 relaxin in the manufacture of a medicament for treating a disease
EP02766975A EP1434599A4 (en) 2001-10-08 2002-10-02 HUMAN RELAXINE 3
IL161291A IL161291A (en) 2001-10-08 2004-04-04 Use of h3 relaxin in the manufacture of medicaments for the treatment of various disorders
US11/892,215 US8841254B2 (en) 2001-10-08 2007-08-21 Method for treatment of anxiety
AU2008201803A AU2008201803B2 (en) 2001-10-08 2008-04-23 Human 3 relaxin
US12/412,519 US20090239805A1 (en) 2001-10-08 2009-03-27 Human 3 relaxin
AU2009208063A AU2009208063A1 (en) 2001-10-08 2009-08-07 Human 3 relaxin
US12/538,128 US20110003750A1 (en) 2001-10-08 2009-08-08 Human 3 relaxin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR8144A AUPR814401A0 (en) 2001-10-08 2001-10-08 Human 3 relaxin

Publications (1)

Publication Number Publication Date
AUPR814401A0 true AUPR814401A0 (en) 2001-11-01

Family

ID=3831972

Family Applications (4)

Application Number Title Priority Date Filing Date
AUPR8144A Abandoned AUPR814401A0 (en) 2001-10-08 2001-10-08 Human 3 relaxin
AU2002331460A Ceased AU2002331460B2 (en) 2001-10-08 2002-10-02 Human 3 relaxin
AU2008201803A Ceased AU2008201803B2 (en) 2001-10-08 2008-04-23 Human 3 relaxin
AU2009208063A Abandoned AU2009208063A1 (en) 2001-10-08 2009-08-07 Human 3 relaxin

Family Applications After (3)

Application Number Title Priority Date Filing Date
AU2002331460A Ceased AU2002331460B2 (en) 2001-10-08 2002-10-02 Human 3 relaxin
AU2008201803A Ceased AU2008201803B2 (en) 2001-10-08 2008-04-23 Human 3 relaxin
AU2009208063A Abandoned AU2009208063A1 (en) 2001-10-08 2009-08-07 Human 3 relaxin

Country Status (9)

Country Link
US (4) US20050026822A1 (enExample)
EP (1) EP1434599A4 (enExample)
JP (1) JP2005508944A (enExample)
KR (1) KR20040063906A (enExample)
AU (4) AUPR814401A0 (enExample)
CA (1) CA2462892A1 (enExample)
IL (2) IL161291A0 (enExample)
NZ (1) NZ532216A (enExample)
WO (1) WO2003030930A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1636384A4 (en) * 2003-06-20 2007-03-07 Amgen Inc GENEAVIFICATION AND OVEREXPRESSION IN CANCER
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
JP4468304B2 (ja) 2004-02-09 2010-05-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 スクリーニング方法
US7878978B2 (en) 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
AU2005223694B2 (en) * 2004-03-19 2011-04-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
AU2011204972B2 (en) * 2004-04-30 2012-05-10 Corthera, Inc. Methods and Compositions for Control of Fetal Growth via Modulation of Relaxin
EP1753449A4 (en) * 2004-04-30 2009-09-23 Corthera Inc METHOD AND COMPOSITIONS FOR CONTROLLING FEDERAL GROWTH BY RELAXIN MODULATION
EP1846443A4 (en) * 2005-01-07 2008-07-23 Glaxo Group Ltd NEW USE
US20090311185A1 (en) * 2005-04-26 2009-12-17 Takayuki Hida Peptide having antianxiety activity and screening method therefor
WO2007027168A1 (en) * 2005-08-29 2007-03-08 Carrier Corporation Compressor muffler
ATE549351T1 (de) * 2007-01-30 2012-03-15 Janssen Pharmaceutica Nv Chimärer peptidantagonist für gpcr135 oder gpcr142
EP2373685A1 (en) * 2008-12-03 2011-10-12 F. Hoffmann-La Roche AG Process for preparing therapeutic peptide
KR101963460B1 (ko) * 2010-08-17 2019-03-28 암브룩스, 인코포레이티드 변형된 릴랙신 폴리펩타이드 및 그것의 용도
WO2012031328A1 (en) * 2010-09-08 2012-03-15 Howard Florey Institute Of Experimental Physiology And Medicine Treatments for substance abuse and addiction
EP2614075B1 (en) * 2010-09-08 2016-10-26 Howard Florey Institute Of Experimental Physiology And Medicine Single chain relaxin polypeptides
GB201110833D0 (en) * 2011-06-24 2011-08-10 Bold Venture Llc Compositions
CN102286092B (zh) * 2011-09-14 2014-01-01 深圳翰宇药业股份有限公司 利拉鲁肽的固相合成方法
WO2013095649A1 (en) * 2011-12-23 2013-06-27 Intel Corporation Apparatus and system for generating a signal with phase angle configuration
CN104133819B (zh) * 2013-05-03 2019-03-01 腾讯科技（深圳）有限公司 信息检索方法及装置
WO2015124540A1 (en) * 2014-02-19 2015-08-27 F. Hoffmann-La Roche Ag Blood brain barrier shuttle
GB201516068D0 (en) * 2015-09-10 2015-10-28 Biomed Ltd B V Novel therapy
EP3458034A4 (en) 2016-05-18 2020-01-01 ModernaTX, Inc. POLYNUCLEOTIDES ENCODING RELAXIN
MX2019008449A (es) 2017-02-08 2019-09-09 Bristol Myers Squibb Co Polipetidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos.
CN114686427B (zh) * 2022-05-23 2022-07-29 中国人民解放军总医院第一医学中心 一种脾脏调节型b淋巴细胞及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166191A (en) 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy
US5478807A (en) 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia
US5911997A (en) 1995-06-07 1999-06-15 Connetics Corporation Relaxin-like factor and methods and uses thereof
US5753623A (en) * 1995-06-07 1998-05-19 Connetics Corporation Method of treatment for depression
JP2001012310A (ja) 1999-06-30 2001-01-16 Takemitsu Kurachi 水蒸気爆発により出力を増す内燃機関
US20020012967A1 (en) * 2000-03-10 2002-01-31 Holloway James L. Insulin homolog polypeptide zins4
EP1294887A1 (en) * 2000-03-10 2003-03-26 ZymoGenetics, Inc. Insulin homolog polypeptide zins4
US7049403B2 (en) * 2000-04-21 2006-05-23 Takeda Pharmaceutical Company Limited Insulin/IGF/relaxin family polypeptides and DNAS thereof
US7409403B1 (en) * 2001-10-30 2008-08-05 Red Hat, Inc. Alert management data infrastructure and configuration generator
US9206927B2 (en) 2012-05-18 2015-12-08 Brian K. Carter Utility conduit supporting device, system, and method

Also Published As

Publication number Publication date
WO2003030930A1 (en) 2003-04-17
US20050026822A1 (en) 2005-02-03
KR20040063906A (ko) 2004-07-14
EP1434599A4 (en) 2006-09-20
US20090239805A1 (en) 2009-09-24
AU2002331460B2 (en) 2008-01-24
IL161291A0 (en) 2004-09-27
AU2008201803A1 (en) 2008-05-15
US8841254B2 (en) 2014-09-23
CA2462892A1 (en) 2003-04-17
NZ532216A (en) 2007-05-31
IL161291A (en) 2011-01-31
AU2008201803B2 (en) 2011-06-30
JP2005508944A (ja) 2005-04-07
EP1434599A1 (en) 2004-07-07
US20080176795A1 (en) 2008-07-24
AU2009208063A1 (en) 2009-08-27
US20110003750A1 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
AUPR814401A0 (en) Human 3 relaxin
IL159890A0 (en) Dolastatin 10 derivatives
AU2002317759A1 (en) Ophthalmoscope
GB0218205D0 (en) Human ZZAP1 protein
AU2002224553A1 (en) Human proteases
AU2001227833A1 (en) 71 human secreted proteins
WO2002018574A3 (en) Human interleukin-four induced protein
AU2001237957A1 (en) 17 human secreted proteins
GB0111314D0 (en) Dermatological formulations
AU2002227925A1 (en) Human beta-defensin-3
AU2001241875A1 (en) Human dynamin 40322
AU2002358719A1 (en) Agaricoglycerides and analogs
AU2002250041A1 (en) Putative human enzymes
AU2002365153A1 (en) 41 human secreted proteins
AU4456800A (en) Human hac3
AU2002360333A1 (en) Human angiomotin-like protein 1
AU2002327176A1 (en) 20 human secreted proteins
AU2001229563A1 (en) 21 human secreted proteins
AU2002246998A1 (en) 50 human secreted proteins
AU2001281116A1 (en) Human serpin zserp15
AU2002257630A1 (en) Human mrp5-like protein
AU2001260116A1 (en) Human dcc-like proteins
AU2002348034A1 (en) 16 human secreted proteins
WO2002086124A8 (en) Human chemokine-13
AU2002231726A1 (en) Human 4-nitrophenylphosphatase